John Mack thinks so:
It could be — as I said before — that all this attention brought on by the lobbying PR snafu is actually helping sales of Gardasil. Or, maybe we haven’t yet seen the negative effects of bad publicity work its way through the sales cycle yet. But Merck seems optimistic.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
